Phillip L. Palmbos

TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors

Scott T. Tagawa, Arjun Vasant Balar, Daniel P. Petrylak et al. · Journal of Clinical Oncology · 2021 · 533 citations · Full text

Medicine, Oncology, Pharmacology +13

Mycobacterial Ku and Ligase Proteins Constitute a Two-Component NHEJ Repair Machine

Marina Della, Phillip L. Palmbos, Hui-Min Tseng et al. · Science · 2004 · 216 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

GM-CSF Mediates Mesenchymal–Epithelial Cross-talk in Pancreatic Cancer

Meghna Waghray, Malica Yalamanchili, Michele Dziubinski et al. · Cancer Discovery · 2016 · 207 citations · Full text

Medicine, Cell Biology, Oncology +17

TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes

Yohann Loriot, Daniel P. Petrylak, Arash Rezazadeh Kalebasty et al. · Annals of Oncology · 2024 · 82 citations · Full text

Medicine, Oncology, Pharmacology +17

Mutations of the Yku80 C Terminus and Xrs2 FHA Domain Specifically Block Yeast Nonhomologous End Joining

Phillip L. Palmbos, James M. Daley, Thomas E. Wilson · Molecular and Cellular Biology · 2005 · 79 citations · Full text

Life Sciences, Genetics, Molecular Biology +17